Use of a living dermal equivalent for a refractory abdominal defect after pediatric multivisceral transplantation

Dermatologic Surgery

Volumn 30, Issue 9, 2004, Pages 1236-1240

  Charles, Carlos A ^a   Kato, Tomoaki ^a   Tzakis, Andreas G ^a   Miller, Barbara N ^c   Kirsner, Robert S ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ARTICLE; ARTIFICIAL SKIN; CASE REPORT; CHILD; EPITHELIZATION; FEMALE; HUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; SKIN FIBROBLAST; SURGICAL WOUND; WOUND HEALING;

ABDOMEN; CULTURE TECHNIQUES; FEMALE; FIBROBLASTS; HUMANS; INFANT; INTESTINE, SMALL; LIVER TRANSPLANTATION; SKIN TRANSPLANTATION; WOUND HEALING;

EID: 4744345267     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30383.x     Document Type: Article

References (22)

1. Alexandrides IJ, Liu P, Marshall DM, et al. Abdominal wall closure after intestinal transplantation. Plast Reconstr Surg 2000;106:805-12.
2. Levi DM, Tzakis AG, Kato T, et al. Transplantation of the abdominal wall. Lancet 2003;361:2173-6.
3. Shun A, Thompson JF, Dorney SFA, Shiel AGR. Temporary wound closure with expanded polytetrafluoroethylene in pediatric liver transplantation. Clin Transplant 1992;6:315-7.
4. Machens HG, Ringe B, Ziemer G, Pichlmayr R. A new procedure for abdominal wound closure after pediatric liver transplantation: the "sandwich" technique. Surgery 1994;115:255-6.
5. Cooper ML, Hansbrough JF, et al. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991;12:243-8.
6. Hansbough JF, Morgan J, Greenleaf G, Underwood J. Development of a temporary living skin replacement composed of human neonatal fibroblasts cultured in Biobrane, a synthetic dressing material. Surgery 1994;115:633-44.
7. Phillips TJ. Biologic skin substitutes. J Dermatol Surg Oncol 1993;19:794-800.
8. Eaglstein WH. Dermagraft treatment of diabetic ulcers. J Dermatol 1998;25:803-4.
9. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19:350-4.
10. Hansbrough JF, Dore C, Hansbrough WB. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil 1992;13:519-29.
11. Omar AA, Mavor AI, Homer-Vanniasinkam S. Evaluation of dermagraft as an alternative to grafting for open fasciotomy wounds. J Wound Care 2002;11:96-7.
12. Pollack RA, Edington H, Jensen J. A human dermal replacement for the treatment of diabetic foot ulcers. Wounds 1997;9:175.
13. Hansbrough JF. Status of cultured skin replacements. Wounds 1995;7:30-6.
14. Galit J, Clark RA. Studies in vitro and the role of alpha v and beta 1 integrins in the adhesion of human dermal fibroblasts to provisional matrix proteins fibronectin, vitronectin, and fibrinogen. 1996;106:102-8.
15. Jiang WG, Harding KG. Enhancement of wound tissue expansion and angiogenesis by matrix-embedded fibroblast (Dermagraft), a role for hepatocyte growth factor/scatter factor. Int J Mol Med 1998;2:203-10.
16. Folkmann J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65-71.
17. Bussolino F, Di Renzo MF, Ziche M, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-41.
18. Phillips TJ, Manzoor J, Rojas A, et al. The longevity of a bilayered skin substitute after application to venous ulcers. Arch Dermatol 2002;138:1079-81.
19. Schmid P, Grenet O, Medina J, et al. An intrinsic antibiotic mechanism in wounds and tissue-engineered skin. J Invest Dermatol 2001;116:471-2.
20. Demling RH, DeSanti L. Management of partial thickness facial burns (comparison of topical antibiotics and bio-engineered skin substitutes). Burns 1999;25:256-61.
21. Gath HJ, Hell B, Zarrinbal R, Bier J, Raguse JD. Regeneration of intraoral defects after tumor resection with a bioengineered human dermal replacement (Dermagraft). Plast Reconstr Surg 2002;109:889-93; discussion 894-5.
22. Falabella AF, Valencia IC, Eaglstein WH, Schachner LA. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 2000;136:1225-30.